Bio-Path Holdings (BPTH) Misses Q3 EPS by 3c

Bio-Path Holdings (NASDAQ: BPTH) reported Q3 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• ’Not your father’s Sandisk’: Rosenblatt starts coverage at Buy